Phreesia, Inc. (NYSE:PHR) COO Sells $172,507.05 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 7,233 shares of the stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total transaction of $172,507.05. Following the completion of the sale, the chief operating officer now owns 776,652 shares in the company, valued at approximately $18,523,150.20. This trade represents a 0.92 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Evan Roberts also recently made the following trade(s):

• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The stock was sold at an average price of $30.06, for a total value of $105,781.14.
• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.

Phreesia Stock Up 0.3 %

Shares of PHR opened at $24.06 on Friday. The company has a market capitalization of $1.41 billion, a PE ratio of -16.37 and a beta of 0.82. The stock’s 50-day moving average price is $26.57 and its two-hundred day moving average price is $24.26. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. KeyCorp raised their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 8th. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, March 13th. Piper Sandler reiterated an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Finally, Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and raised their price objective for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $31.33.

Institutional Trading of Phreesia

Several institutional investors have recently added to or reduced their stakes in PHR. Vanguard Group Inc. grew its holdings in Phreesia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock worth $121,349,000 after acquiring an additional 61,048 shares during the period. Greenhouse Funds LLLP raised its position in shares of Phreesia by 27.9% during the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after purchasing an additional 626,579 shares during the period. Franklin Resources Inc. raised its holdings in Phreesia by 0.8% during the fourth quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company’s stock worth $37,982,000 after buying an additional 11,986 shares during the last quarter. State Street Corp lifted its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C lifted its holdings in shares of Phreesia by 133.6% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock valued at $31,999,000 after purchasing an additional 727,384 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.